Parnell Pharmaceuticals Holdings Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 78
Employees
  • Stock Symbol
  • PARNF
Stock Symbol
  • Share Price
  • $0.11
  • (As of Thursday Closing)

Parnell Pharmaceuticals Holdings General Information

Description

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
PINX
Primary Office
  • PO Box 1035
  • Mascot, New South Wales 1460
  • Australia
+1 000000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Parnell Pharmaceuticals Holdings Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.11 $0.12 $0.04 - $0.36 6.84K

Parnell Pharmaceuticals Holdings Financials Summary

In Thousands,
USD
TTM 31-Dec-2018 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017 FY 2016 31-Dec-2016
EV 26,116 26,116 27,255 20,508
Revenue 19,817 19,817 14,654 14,158
EBITDA 6,848 6,848 (4,840) (11,938)
Net Income 97 97 (17,719) (16,122)
Total Assets 23,586 23,586 23,559 34,266
Total Debt 31,728 31,728 25,104 21,492
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Parnell Pharmaceuticals Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Parnell Pharmaceuticals Holdings‘s full profile, request access.

Request a free trial

Parnell Pharmaceuticals Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developin
Pharmaceuticals
Mascot, Australia
78 As of 2016
000.00
000000000 000.00

0000 000

consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nu
000000000000000
Libourne, France
0000 As of 0000
00000
000000000 00000

00000000

ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
0000 00000000
Greensboro, NC
00 As of 0000
000.00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Parnell Pharmaceuticals Holdings Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ceva Sante Animale Private Equity-Backed Libourne, France 0000 00000 000000000 00000
00000000 000000 00 Venture Capital-Backed Greensboro, NC 00 000.00 000000000000 000.00
000000 Corporation Maharashtra, India 0000
00000 Corporation Leverkusen, Germany 000000 00.00 000000000 00.00
To view Parnell Pharmaceuticals Holdings’s complete competitors history, request access »

Parnell Pharmaceuticals Holdings Executive Team (5)

Name Title Board Seat Contact Info
Robert Joseph Chief Executive Officer & Board Member
Wesley Dittmer Senior Vice President & North American Chief Financial Officer
Brad McCarthy Chief Financial Officer, Finance & Board Member
Matt Musselman Chief Commercial Officer
Edward Robb Chief Scientific Officer
To view Parnell Pharmaceuticals Holdings’s complete executive team members history, request access »

Parnell Pharmaceuticals Holdings Board Members (2)

Name Representing Role Since
0000 00000000 Parnell Pharmaceuticals Holdings Chief Financial Officer, Finance & Board Member 000 0000
000000 000000 Parnell Pharmaceuticals Holdings Chief Executive Officer & Board Member 000 0000
To view Parnell Pharmaceuticals Holdings’s complete board members history, request access »

Parnell Pharmaceuticals Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial